Tenderwize
Retour à la recherche

Open House Discount Agreement for Ribociclib

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 131 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ribociclib, ATC L01EF02

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

30 / 100

Facteurs de risque

Buyer may replace open-house agreements with exclusive discount contracts during the term, potentially terminating exis...

No guaranteed purchase volumes; financial benefit depends on market share and prescribing behavior.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 28, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount agreements for pharmaceutical products containing the active ingredient Ribociclib (ATC L01EF02).
  • Agreements cover the period from 01.05.2025 to 30.04.2027 (24 months maximum).
Afficher le résumé complet

This is an open-house procedure by AOK Rheinland-Pfalz/Saarland for non-exclusive discount agreements on the active ingredient Ribociclib (ATC L01EF02). The agreement is for a maximum of 24 months, starting 01.05.2025, with monthly accession possibilities. It is explicitly stated as not a public procurement under EU Directive 2014/24/EU, but published for transparency. No estimated value is provided. The procedure is open to all interested pharmaceutical companies with authorized and marketable medicines in Germany. The first submission deadline for a start on 01.05.2025 is 31.03.2025; later submissions can be made monthly. The buyer may replace these open-house agreements with exclusive discount contracts during the term.

Risques

Buyer may replace open-house agreements with exclusive discount contracts during the term, potentially terminating exis...

No guaranteed purchase volumes; financial benefit depends on market share and prescribing behavior.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Medicines must be authorized and marketable in Germany.
  • Evidence of marketability via Lauer-Taxe listing or DIMDI AMIce database extracts.
  • Participation is open to all pharmaceutical companies; no selection or negotiation.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria explicitly specified; participation is open to all eligible companies meeting the conditions.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Agreement for Ribociclib

Non-exclusive discount agreements for Ribociclib (ATC L01EF02) under an open-house model. All interested pharmaceutical companies meeting the eligibility criteria can participate without selection. Contracts last up to 24 months, with start dates on the first of each month. The buyer may replace these with exclusive contracts during the term.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria explicitly specified; participation is open to all eligible companies meeting the conditions.

Date limite

Deadline Feb 28, 2027

Détails de la procédure

Date de publication
20 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
184252-2025

Documents (1)

Appels d'offres similaires